Celldex Therapeutics   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Hampton NJ United States (1983)

Organization Overview

First Clinical Trial
2004
NCT00709462
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Celldex Therapeutics | CellDex Therapeutics